Distinctive expression and cellular distribution of dopamine receptors in the pancreatic islets of rats

New perspectives of vesicular monoamine transporter 2 chemical characteristics in mammals and its constant expression in type 1 diabetes rat models

(2013) Feng Hong et al.   Translational Research

Dopamine Synthesis and D3 Receptor Activation in Pancreatic β-Cells Regulates Insulin Secretion and Intracellular [Ca2+] Oscillations

(2012) Alessandro Ustione et al.   MOLECULAR ENDOCRINOLOGY

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

(2011) R. A. DeFronzo   DIABETES CARE

High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice

(2011) M. Bousquet et al.   NEUROBIOLOGY OF DISEASE

Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats

(2011) J.K. Morris et al.   NEUROSCIENCE LETTERS

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

(2010) J.E. de Leeuw van Weenen et al.   BIOCHEMICAL PHARMACOLOGY

Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance

(2010) Isabel García-Tornadú et al.   ENDOCRINOLOGY

Dopamine D1-like receptor antagonist, SCH23390, exhibits a preventive effect on diabetes mellitus that occurs naturally in NOD mice

(2009) Kumiko Hashimoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes

(2009) Richard Scranton et al.   EXPERT OPINION ON PHARMACOTHERAPY

β-Adrenoceptors, but not dopamine receptors, mediate dopamine-induced ion transport in late distal colon of rats

(2008) Xiao-Hui Zhang et al.   CELL AND TISSUE RESEARCH